Xue Jun Su
Director/Board Member at SSY GROUP LIMITED
Net worth: 15 M $ as of 30/05/2024
Profile
Xue Jun Su is currently an Executive Director at SSY Group Ltd.
and New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
Previously, he worked as Deputy Chairman at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
and as a Factory Manager at Shijiazhuang No 1 Pharmaceutical Factory.
Mr. Su obtained an undergraduate degree from Hebei Normal University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SSY GROUP LIMITED
0.82% | 29/06/2023 | 24,416,000 ( 0.82% ) | 15 M $ | 30/05/2024 |
Xue Jun Su active positions
| Companies | Position | Start |
|---|---|---|
| SSY GROUP LIMITED | Director/Board Member | 14/12/2014 |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Director/Board Member | 06/01/2007 |
Former positions of Xue Jun Su
| Companies | Position | End |
|---|---|---|
| Shijiazhuang No 1 Pharmaceutical Factory | Corporate Officer/Principal | - |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Chairman | - |
Training of Xue Jun Su
| Hebei Normal University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
| Shijiazhuang No 1 Pharmaceutical Factory |
- Stock Market
- Insiders
- Xue Jun Su
